Background. Adhesions to polypropylene mesh used for abdominal wall hernia repair may eventuate in intestinal obstruction or enterocutaneous fistula. A Seprafilm Bioresorbable Membrane translucent adhesion barrier has been shown to inhibit adhesions. This investigation was designed to determine if Seprafilm alters abdominal visceral adhesions to polypropylene mesh. Methods. A 2.5-cm square abdominal muscle peritoneal defect was created and corrected with polypropylene mesh. Mesh alone was used in 17 rats. In another 17, the Seprafilm membrane was applied between the viscera and the mesh. Five animals had the bioresorbable membrane placed in the subcutaneous space and between the mesh and the viscera. Laparoscopy was performed 7, 14, and 28 days later to evaluate adhesions as a percentage of mesh surface involved. Results. Polypropylene mesh alone was associated with adhesions in every rat. The average area involved was 90%, the minimum was 75%. Adhesions were present within 24 hours and progressed up to 7 days with no change thereafter. When the Seprafilm barrier was used, the mean area involved was 50%. In 16 such rats, the area involved was smaller than any control animal. No adhesions formed in 5 animals. Scanning electron microscopy demonstrated a mesothelial cell layer covering the mesh after 4 weeks. Conclusions. The use of the Seprafilm adhesion barrier resulted in a significant reduction of adhesion formation to polypropylene mesh (P <.001). (Surgery 2000;128:86-92)
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Incisional hernia: A 10-year prospective study of incidence and attitudes.Br J Surg. 1985; 72: 70-71
- The need for mesh.in: Prostheses and abdominal wall hernias. : R.G. Landes Company, Austin (Texas)1994: 116-122
- Use of a mesh for musculoaponeurotic defects of the abdominal wall in cancer surgery and the risk of bowel fistulas.J Am Coll Surg. 1995; 181: 11-16
- Fecal fistula: a late complication of Marlex mesh repair.Dis Colon Rectum. 1981; 24: 543-544
- Management of acute full-thickness losses of abdominal wall.Ann Surg. 1981; 193: 612-618
- Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane. A prospective, randomized, double-blind multicenter study.J Am Coll Surg. 1996; 183: 297-306
- Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): A blinded, prospective, randomized multicenter clinical study.Fertil Steril. 1996; 66: 904-910
- A novel hyaluronate-based gel in laparoscopic adhesion prevention: preclinical evaluation in an animal model.Fertil Steril. 1998; 69: 318-323
- Effect of hyaluronic acid on postoperative intraperitoneal adhesion formation in the rat model.Fertil Steril. 1991; 56: 563-567
- Reduction of adhesion formation by postoperative administration of ionically cross-linked hyaluronic acid.Fertil Steril. 1997; 68: 37-42
- Prevention of adhesions by Seprafilm, an absorbable adhesion barrier: an incisional hernia model in rats.Am Surg. 1997; 63: 818-819
- A simple and sensitive method for the quantitative estimation of collagen.Anal Biochem. 1979; 94: 96-99
- Preclinical evaluation of Seprafilm¿ bioresorbable membrane.Eur J Surg. 1997; 577: 40-48
- Regeneration of parietal and visceral peritoneum: an electron microscopical study.J Anat. 1973; 115: 375-392
- Postoperative adhesion development after operative laparoscopy: evaluation at early second-look procedures.Fertil Steril. 1991; 55: 700-704
- Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells.Blood. 1990; 7: 1490-1497
Accepted: February 27, 2000
*Supported by grants from the Genzyme Corporation.
**Reprint requests: John P. Delaney, MD, PhD, University of Minnesota, Health Sciences Center, Box 89, 420 Delaware St, SE, Minneapolis, MN 55455.
© 2000 Mosby, Inc. Published by Elsevier Inc. All rights reserved.